SUBCLINICAL PRIMARY ALDOSTERONISM

Clinical trials for SUBCLINICAL PRIMARY ALDOSTERONISM explained in plain language.

Never miss a new study

Get alerted when new SUBCLINICAL PRIMARY ALDOSTERONISM trials appear

Sign up with your email to follow new studies for SUBCLINICAL PRIMARY ALDOSTERONISM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Could a common heart drug stop high blood pressure before it starts?

Prevention Not yet recruiting

This trial tests whether eplerenone, a drug that blocks the hormone aldosterone, can prevent the onset of high blood pressure in people aged 30–55 who have a mild, early form of primary aldosteronism but normal blood pressure. Participants will receive either eplerenone or a plac…

Matched conditions: SUBCLINICAL PRIMARY ALDOSTERONISM

Phase: PHASE2, PHASE3 • Sponsor: Xinjiang Medical University • Aim: Prevention

Last updated Jul 29, 2026 00:00 UTC

SUBCLINICAL PRIMARY ALDOSTERONISM

Get alerted when new SUBCLINICAL PRIMARY ALDOSTERONISM trials appear

Could a common heart drug stop high blood pressure before it starts?